Quest for the right Drug

|
עמוד הבית / קיופנס 200 מ"ג / מידע מעלון לרופא

קיופנס 200 מ"ג CUFENCE 200 MG (TRIENTINE AS DIHYDROCHLORIDE)

תרופה במרשם תרופה בסל נרקוטיקה ציטוטוקסיקה

צורת מתן:

פומי : PER OS

צורת מינון:

קפסולה קשיחה : HARD CAPSULE

Interactions : אינטראקציות

4.5    Interaction with other medicinal products and other forms of interaction

No interaction studies have been performed.
Zinc
There are insufficient data to support the concomitant use of zinc and trientine. The combination of trientine with zinc is not recommended as interaction of zinc with trientine is likely, thereby reducing the effect of both active substances.

Other anti-copper agents
No interaction studies have been performed on the concomitant administration of trientine with D- Penicillamine.

Food

Trientine is poorly absorbed following oral intake and food further inhibits trientine absorption. Specific food interaction studies have been performed with trientine in healthy subjects, showing a reduction of the extent of absorption of trientine up to 45%. Systemic exposure is critical for its principal mechanism of action, copper chelation (see section 5.1). Therefore, it is recommended that trientine is taken at least 1 hour before meals or 2 hours after meals and at least one hour apart from any other medicinal product, food, or milk to allow for maximum absorption and reduce the likelihood of the formation of complexes by metal binding in the gastrointestinal tract (see section 4.2).
3
Other products
Trientine has been found to reduce serum iron levels. Therefore, iron supplementation may be necessary in some cases. Concomitant oral iron or other heavy metals should be administred at a different time than trientine to prevent the formation of complexes (see section 4.4).

Although there is no evidence that calcium and magnesium antacids alter the efficacy of trientine, it is good practice to separate their administration (see section 4.4).

שימוש לפי פנקס קופ''ח כללית 1994 לא צוין
תאריך הכללה מקורי בסל לא צוין
הגבלות לא צוין

בעל רישום

MBI PHARMA LTD., ISRAEL

רישום

165 12 35600 00

מחיר

0 ₪

מידע נוסף

עלון מידע לרופא

20.01.21 - עלון לרופא

עלון מידע לצרכן

17.09.20 - עלון לצרכן עברית

לתרופה במאגר משרד הבריאות

קיופנס 200 מ"ג

קישורים נוספים

RxList WebMD Drugs.com